Physician profile
Joy D Jester
NPI 1487643334
$3,242.11
in general payments reported to CMS, 2019-2025
22 companies · $329 in 2025
The $329 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $418 · 2021: $848 · 2022: $585 · 2023: $217 · 2024: $244 · 2025: $329.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.68 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $730.29 | 2019-2024 | |
| Abbvie INC. | $713.41 | 2019-2025 | |
| Amgen INC. | $309.49 | 2019-2025 | Otezla |
| Janssen Biotech, INC. | $230.96 | 2021-2022 | |
| Galderma Laboratories, L.P. | $204.32 | 2025 | Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $193.89 | 2019 | |
| Novartis Pharmaceuticals Corporation | $177.96 | 2021-2024 | |
| Ucb, INC. | $105.04 | 2019-2024 | Bimzelx |
| Janssen Scientific Affairs, LLC | $99.84 | 2021 | |
| Sun Pharmaceutical Industries INC. | $89.84 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.94 | 2022-2023 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $51.02 | 2024-2025 | Zoryve |
| Sanofi-Aventis U.S. LLC | $49.30 | 2020-2021 | |
| Lilly USA, LLC | $40.53 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $33.45 | 2021-2023 | Dupixent |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $32.70 | 2019-2020 | |
| Incyte Corporation | $28.07 | 2023 | Opzelura |
| Dermavant Sciences, INC. | $25.90 | 2023 | Vtama |
| Dermira, INC. | $24.37 | 2020 | |
| Celgene Corporation | $19.19 | 2019 | |
| Leo Pharma INC. | $17.03 | 2024 | Adbry |
| Organon LLC | $12.57 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joy Jester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.